bpc 157 evidence human clinical trials fda warning BPC-157: The peptide with big claims and scant Regeneration or Risk? A Narrative
Description
Source quality and testing Peptide quality directly affects both safety and efficacy
The patient interest comes mostly from athletes and recovery-focused patients
Injections can be weekly while refills are made on follow-ups.
The per-milligram price does
Most patients report minimal discomfort
Sport and international status AOD-9604 is on the World Anti-Doping Agency Prohibited List under section S2.2
